Abzena, Supplies Abzena Supplies Clinical Trial Material for Angiex's Phase I Study of AGX101, a First-in-Class TM4SF1-directed ADC 07.08.2025 - 18:05:44 Abzena United Kingdom United States of America California View original content:https://www.prnewswire.co.uk/news-releases/abzena-supplies-clinical-trial-material-for-angiexs-phase-i-study-of-agx101-a-first-in-class-tm4sf1-directed-adc-302218385.html